About 2 700 reports

Shanghai Pioneer Pharmaceutical Co., Ltd. is an integrated biopharmaceutical company engaged in research/ development, manufacture and marketing/ sales of biopharmaceutical products in China.

  • Biopharmaceutical
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • PROVIDES THE DRUGS IN THE PHASE I AND PHASE II PIPELINE FOR MS.
  • ITOLIZUMAB

EUROPEAN NEUROLOGY; ##(SUPPL ##):##-##.

  • Biopharmaceutical
  • United States
  • Forecast
  • Biogen Idec Inc.
  • Novartis AG

Global and China Monoclonal Antibody Industry Report, 2019-2025 ##.

  • Biopharmaceutical
  • Medical Biotechnology
  • Monoclonal Antibody
  • China
  • Market Size

You can easily book an appointment with one online.

  • Biopharmaceutical
  • World
  • Amgen Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.

SUNSHINE is now one of the largest biopharmaceutical companies in China in terms of market shares, growth and profitability.

  • Biopharmaceutical
  • China
  • Demand
  • Harbin Pharmaceutical Group
  • North China Pharmaceutical Group Corp.
  • ANGLO GULF ACQUIRES 50.01% STAKE IN SCIGEN BIOPHARMA FOR USD7 MILLION
  • SCIGEN SELLS JV STAKE IN HEFEI-SCIGEN-BIOTON BIOPHARMA FOR US$3.5 MILLION

GlobalData Bioton SA reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Biopharmaceutical
  • Deals & Alliance
  • M&A
  • Supply
  • Bioton S.A.
  • Benitec Biopharma Ltd, Subsidiaries
  • Benitec Biopharma Ltd - Key Competitors

DEAL RATIONALE Cal-## is under development for the treatment of HIV-## Infection.

  • Biopharmaceutical
  • Therapy
  • United States
  • Company
  • Benitec Biopharma Limited
  • Benitec Biopharma Ltd, Subsidiaries
  • Benitec Biopharma Ltd, Key Competitors

Assuming approval on a normal time-frame, Benitec should be starting a Phase ##/ ## clinical study with BB-## by the end of calendar year 2018.

  • Biopharmaceutical
  • United States
  • Company
  • Company Operations
  • Benitec Biopharma Limited

Ltd ##. ##. ## Soluble Systems, LLC ##. ##. ## Smith & Nephew plc ##. ##. ## Shire Pharmaceuticals Group PLC ##. ##. ## Beike Biotechnology Co., Ltd. ##. ##. ## SanBio, Inc. ##. ##. ## ReNeuron Group plc ##. ##. ## Regeneus Ltd. ##. ##. ## Regen BioPharma, Inc ##. ##. ## Q Therapeutics, Inc. ##. ##. ## Promethera Biosciences

  • Biopharmaceutical
  • Medical Biotechnology
  • United States
  • Forecast
  • Market Size
  • THERAPURE BIOPHARMA
  • 168 TANVEX BIOPHARMA

##.

  • Biopharmaceutical
  • Cell Therapy
  • Abzena plc
  • Lonza Group Ltd
  • Selexis SA
  • Sutro Biopharma Inc - Key Competitors
  • Sutro Biopharma Inc, Other Locations

Draft Registration Statement: On June ##, 2018, Sutro Biopharma filed a draft registration statement with the US SEC for IPO of shares of common stock.

  • Biopharmaceutical
  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Principia Biopharma Inc - Key Competitors
  • ABBVIE AND PRINCIPIA BIOPHARMA ENTER INTO AGREEMENT

SR One Ltd.

  • Biopharmaceutical
  • Healthcare
  • United States
  • Company
  • BioPharma company
  • Techpool Bio-Pharma Co Ltd, Key Employees
  • Techpool Bio-Pharma Co Ltd, Other Locations

GlobalData is one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Biopharmaceutical
  • Pharmaceutical
  • China
  • M&A
  • TECHPOOL Bio-Pharma Co., Ltd.
  • GENOR BIOPHARMA CO LTD - LOCATIONS AND SUBSIDIARIES
  • GENOR BIOPHARMA CO LTD, KEY COMPETITORS

One clinical candidate-NBT## ADC-## selected by Genor Pharma will go for further development for IND application in 2016.

  • Biopharmaceutical
  • Medical Biotechnology
  • China
  • M&A
  • Genor
  • Propanc Biopharma Inc, Subsidiaries
  • Propanc Biopharma Inc - Key Competitors

Network ## Financial Securities, Inc. is acting as agent for the financing.

  • Biopharmaceutical
  • Healthcare
  • Australia
  • Company
  • BioPharma company
  • ASKLEPIOS BIOPHARMACEUTICAL INC - LOCATIONS AND SUBSIDIARIES
  • ASKLEPIOS BIOPHARMACEUTICAL INC - KEY EMPLOYEES

GlobalData Asklepios BioPharmaceutical Inc, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Biopharmaceutical
  • United States
  • Company
  • Deals & Alliance
  • Asklepios BioPharmaceutical, Inc.
  • Therapure Biopharma Inc - Key Competitors
  • Therapure Biopharma Inc, Key Employees

GlobalData Therapure Biopharma Inc' s, deal volume increased from one pharmaceuticals & healthcare deal in 2016 to two pharmaceuticals & healthcare deals in 2017.

  • Biopharmaceutical
  • Medical Biotechnology
  • Canada
  • Deals & Alliance
  • BioPharma company
  • AZURRX BIOPHARMA INC
  • AZURRX BIOPHARMA INC, SUBSIDIARIES

THE AGREEMENT ENABLES AZURRX BIOPHARMA TO TACKLE ONE OF THE MAJOR FRONTIERS IN MEDICINE, THE IMPACT OF BACTERIAL BIOFILMS ON HUMANS.

  • Biopharmaceutical
  • Hospital
  • United States
  • Corporate Finance
  • BioPharma company
  • Keryx Biopharmaceuticals Inc, Subsidiaries
  • Keryx Biopharmaceuticals Inc, Key Competitors

GlobalData Keryx Biopharmaceuticals Inc, reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Demand
  • Biopharmaceuticals Inc.
  • CORP, REDHILL BIOPHARMA LTD
  • REDHILL BIOPHARMA LTD, SUBSIDIARIES

REDHILL BIOPHARMA WILL PAY RESPROTECT FOR A ONE YEAR OPTION, WHICH MAY BE EXTENDED BY REDHILL BIOPHARMA UNDER CERTAIN AGREED TERMS.

  • Biopharmaceutical
  • Gastrointestinal Drug
  • Therapy
  • United States
  • RedHill Biopharma Ltd.
  • ARRAY BIOPHARMA INC, KEY COMPETITORS
  • ARRAY BIOPHARMA INC - LOCATIONS AND SUBSIDIARIES

Array Biopharma Inc., No. ##:##-cv- ## was filed on November ##, 2017.

  • Biopharmaceutical
  • Pharmaceutical
  • Therapy
  • United States
  • BioPharma company
  • ALDER BIOPHARMACEUTICALS INC, SUBSIDIARIES
  • ALDER BIOPHARMACEUTICALS INC - KEY COMPETITORS

Deal History:Completed: On February ##, 2018, Alder Biopharma completed the public offering of ##. ##% convertible senior notes due February ##, 2025, for gross proceeds of USD## million.

  • Biopharmaceutical
  • Pain Relief
  • United States
  • Company
  • Biopharmaceuticals Inc.
  • CTI BIOPHARMA CORP, SUBSIDIARIES
  • CTI BIOPHARMA CORP - KEY EMPLOYEES

It targets JAK##-selective kinase, FMS-like tyrosine kinase ##, colony stimulating factor ## receptor (CSF##R) and interleukin-## receptor-associated kinase ## (IRAK##).

  • Biopharmaceutical
  • United States
  • Company
  • Corporate Finance
  • CTI BioPharma Corp.
  • Hemispherx Biopharma Inc, Subsidiaries
  • Hemispherx Biopharma Inc, Other Locations

J. D., Chief Executive Officer of Hemispherx Biopharma, will be presenting as well as meeting with investors one-on-one.

  • Biopharmaceutical
  • Therapy
  • United States
  • Supply
  • BioPharma company
  • Theravance Biopharma Inc, Key Competitors
  • Theravance Biopharma Inc - Key Employees

TD-##: Phase ## SAD study in healthy volunteers completed in Q## 2017.

  • Biopharmaceutical
  • United States
  • Company
  • Company Financials
  • BioPharma company
  • PDL BIOPHARMA INC, SUBSIDIARIES
  • PDL BIOPHARMA INC - LOCATIONS AND SUBSIDIARIES

GlobalData PDL BioPharma Inc reported one pharmaceuticals & healthcare deal worth $##. ## million in YTD 2018.

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Company
  • BioPharma company
  • UNITED BIOPHARMA INC, OTHER LOCATIONS
  • UNITED BIOPHARMA INC - LOCATIONS AND SUBSIDIARIES

The key sources used include: METHODOLOGY GlobalData is one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Biopharmaceutical
  • China
  • Taiwan
  • Deals & Alliance
  • BioPharma company
  • MATINAS BIOPHARMA HOLDINGS INC, SUBSIDIARIES
  • MATINAS BIOPHARMA HOLDINGS INC, KEY COMPETITORS

Details of the MAT## presentations are as follows: About MAT## MAR ##, 2017: MATINAS BIOPHARMA REPORTS POSITIVE TOPLINE DATA FROM PHASE ## STUDY OF MAT## Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company focused on developing innova

  • Anti-Infective
  • Biopharmaceutical
  • United States
  • Company
  • Matinas BioPharma Holdings, Inc.
  • Mereo Biopharma Group Plc, Subsidiaries
  • MEREO BIOPHARMA POSTPONES PUBLIC OFFERING OF ADS

One of the study objectives was the comparison between all three groups.

  • Biopharmaceutical
  • United Kingdom
  • United States
  • Company
  • Mereo Biopharma Group Limited
  • Adgero Biopharma Raises USD9.7 Million in Equity Financing
  • Adgero Biopharmaceuticals Holdings Inc - Key Employees

Business Description GlobalData Adgero Biopharmaceuticals Holdings Inc - Key Competitors Adgero Biopharmaceuticals Holdings Inc, Key Competitors Adgero Biopharmaceuticals Holdings Inc - Key Employees Adgero Biopharmaceuticals Holdings Inc, Key Employees HEAD OFFIC

  • Biopharmaceutical
  • Therapy
  • Company
  • Corporate Finance
  • Adgero Biopharmaceuticals, Inc.